Celula-China

BiotechnologySeries BChengdu, Chinacelula-china.com

Latest round

Series B

Last raised

Feb 2021

Total raised

Undisclosed

Investors

7

About Celula-China

Based in Chengdu, China and established in 2013, Celula-China operates as a gene detection company which focuses on oncology and reproductive health. It provides related diagnostic reagent and equipment. The company has established a production and service base of more than 5,000 square meters, branch offices in Shanghai, Zhuhai, and offices in Beijing and many provinces of China respectively. The company's main products include non-invasive prenatal testing products and Sparrow flow cytometry. Among them, the non-invasive prenatal testing products are capable of efficiently analyzing the genetic defects and health status of fetuses.

Who invested in Celula-China

7 investors across 3 rounds

See all investors in Celula-China

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Feb 20, 2021

    Amount

    Undisclosed

    Investors

    Locked

  2. Series B

    Sep 7, 2020

    Amount

    Undisclosed

    Investors

    Locked

  3. Series A

    Oct 9, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about Celula-China

Who invested in Celula-China?

Celula-China has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Celula-China raised?

Celula-China has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Celula-China last raise money?

Celula-China's most recent round on record is a Series B, in Feb 2021.

What does Celula-China do?

Based in Chengdu, China and established in 2013, Celula-China operates as a gene detection company which focuses on oncology and reproductive health.

Where is Celula-China headquartered?

Celula-China is headquartered in Chengdu, China.

Which VCs invest in companies like Celula-China?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Celula-China's stage. Their profiles are linked below.

Raising like Celula-China? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.